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Abstract
Sexual partnerships that overlap in time (concurrent relationships) may play a significant
role in the HIV epidemic, but the precise effect is unclear. We derive edge-based compartmental
models of disease spread in idealized dynamic populations with and without concurrency to
allow for an investigation of its effects. Our models assume that partnerships change in time and
individuals enter and leave the at-risk population. Infected individuals transmit at a constant
per-partnership rate to their susceptible partners. In our idealized populations we find regions
of parameter space where the existence of concurrent partnerships leads to substantially faster
growth and higher equilibrium levels, but also regions in which the existence of concurrent
partnerships has very little impact on the growth or the equilibrium. Additionally we find mixed
regimes in which concurrency significantly increases the early growth, but has little effect on the
ultimate equilibrium level. Guided by model predictions, we discuss general conditions under
which concurrent relationships would be expected to have large or small effects in real-world
settings. Our observation that the impact of concurrency saturates suggests that concurrency-
reducing interventions may be most effective in populations with low to moderate concurrency.
Introduction
The HIV epidemic has had a significant impact worldwide, but especially so in sub-Saharan
Africa [33]. The reasons for this difference are many, complex, and not fully understood [4, 12].
One proposed factor is a greater frequency of sexual partnerships that overlap in time, the so-called
“concurrency hypothesis” [31, 32]. This hypothesis has received significant attention, but it is
highly controversial (see for example [25, 24, 26, 30, 8, 23, 16] and [39, 9, 10]).
Mechanisms of concurrency
It is worth exploring a simplified scenario to illustrate the key mechanisms by which concurrency
can affect disease transmission as well as some of the subtleties, which make ultimate impact less
obvious and make observational study design difficult. Consider an individual “Alex” who has two
partners “Bobbie” and “Charlie” over a period of one year. Two potential partnership arrangements
are shown in Fig. 1. In the serial case (top of Fig. 1), Alex’s partnership with Bobbie lasts for six
months and is replaced by a six-month partnership with Charlie. In the concurrent case (bottom of
Fig. 1), Alex’s partnerships with Bobbie and Charlie overlap completely. During each partnership,
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Figure 1: Sample scenarios comparing serially monogamous (top) and concurrent (bot-
tom) relationships: Shaded regions denote the existence of a partnership between “Alex” and
either “Bobbie” or “Charlie”, with darker shading representing a partnership having a higher
transmission rate. Dashed lines denote transmission events within the relationship that would
cause infection if one individual were infected and the other susceptible. Vertical red lines denote
time at which an individual is infected, and horizontal red lines denote successful transmissions. In
the concurrent case, the transmission events occur at exactly the same times, but the transmission
could occur in either partnership. Thus the interaction rate within each partnership is half that of
the serial case. Concurrency provides additional transmission routes and tends to speed up onwards
transmission. In the left panels Bobbie begins infected, in the cenral panels Alex begins infected,
and in the right panels Charlie begins infected.
there are occasional “transmission events”, or interactions between the individuals that would
cause infection if one individual were infected and the other susceptible. If a transmission event
occurs between an infected and a susceptible individual, then it is “successful” and the susceptible
individual becomes infected. In Fig. 1, and throughout this paper, we assume that the rate of
potentially infectious interactions per individual is the same. Thus in a population of only serial
partnerships, the rate of interactions per partnership is twice that in a population with exactly two
overlapping partnerships per individual. The partnership duration is scaled so that the expected
number of transmission events per partnership is the same. This allows us to ensure that in our
comparisons the only change is the level of concurrency, and our results are not conflated with the
effect of increased interactions per individual or per partnership. This is illustrated in Fig. 1 by
halving the temporal density of transmission events and doubling the partnership duration in the
concurrent case.
First consider direct transmission to Alex from Bobbie or Charlie. Regardless of the partner-
ship arrangement or which partner is initially infected, the overall risk of infection to Alex is the
same. However, the timing of infection differs. If Bobbie is initially infected, then Alex tends to
be infected earlier in a serial partnership than a concurrent one (because of the focused relation-
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ship). Conversely, if Charlie is initially infected, then Alex becomes infected earlier in a concurrent
partnership (because of the delay forced by partnership timing in the serial case).
Now consider indirect transmission between Bobbie and Charlie via Alex. Significant differences
in both the risk and timing of infection now exist depending on partnership arrangement. If Charlie
is initially infected, then a transmission chain from Charlie to Alex to Bobbie is only possible in the
concurrent case. If Bobbie is initially infected, then a transmission chain from Bobbie to Alex to
Charlie will happen faster in the concurrent case because there is no built-in delay for partnership
change. In turn this would allow Charlie to begin transmitting to other partners earlier. However,
the probability of a Bobbie to Alex to Charlie transmission chain is slightly reduced because some of
the interactions between Alex and Charlie will already have happened by the time Alex is infected
(see Fig. 7 later).
Finally, consider the result if Alex enters the partnerships already infected. The outcomes are
the same regardless of whether the populations have concurrency, but concurrency tends to reduce
the average time to transmission because the partnerships can start sooner. Unless Bobbie or
Charlie also have concurrent relationships, this has no population-scale impact.
Thus we anticipate that concurrency will increase the spread of disease through two key mech-
anisms: by allowing the disease to trace transmission routes faster and by providing additional
transmission routes. The subtleties described above can limit the extent of its effect. Whether one
individual has concurrent relationships only affects the outcome of a particular partnership if both
partners are susceptible at the beginning of their partnership and at least one becomes infected
during it. Furthermore, the identical risk of infection to Alex regardless of partnership arrangement
in Fig. 1 illustrates that the risk of concurrency is to partners of the individual with concurrent
relationships rather than to the individual with concurrent relationships.
Modeling approaches
Unfortunately, measuring or predicting the magnitude of the impact of concurrency has been diffi-
cult. Concurrency is difficult to directly measure. Even when it is identified, observational studies
comparing an individual with serial relationships to an individual with overlapping relationships
within a given sample population will not test for the effects of concurrency. Instead the study
would need to compare their partners, which is more difficult.
Modeling studies have a different set of challenges. Models are usually either stochastic agent-
based simulation [which we will call “stochastic simulations” or simply “simulations”] or equation-
based [which we will call “analytic models”]. Stochastic simulation of concurrency is often difficult
because of inherent difficulties in identifying which of many parameters governs an outcome as
well as computational limitations on the populations considered. Analytic models in contrast have
difficulties because the standard well-mixed population assumption of analytic models precludes
the existence of concurrent relationships. There is a need for analytic modeling that avoids this
assumption.
Because analytic models have not existed for populations with concurrent relationships, most
modeling investigations of concurrency have used stochastic simulation. Many are reviewed in [9].
Recent work on analytic models has shown how they can be used to incorporate some partnership
structure [35, 43, 15]. The work of [19, 20, 18] in particular used analytic models to investigate
how concurrency alters the epidemic threshold. The very recent work of [17] provides a renewal
equation from which dynamics of a model (similar to the one we present below) can be calculated.
The model of [13] also provides a dynamic prediction, but it makes simplifying assumptions about
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the independence of partner status, partnership age, and partner age. Where correlations build up
this can lead to erroneous predictions.
Recent work [40, 41, 27, 28, 29] developed an “Edge-Based Compartmental Modeling” (EBCM)
approach which leads to differential equation models with only a handful of equations. The mod-
els exactly predict the large population dynamics of SI and SIR disease spread in static random
networks [6, 11]. The approach has been generalized to networks with changing partnerships, but
still assuming a closed population [28]. Because the HIV epidemic developed over decades, it is not
appropriate to ignore individuals entering and leaving the at-risk population as they age. Further,
if we ignore “birth” and “death” for an SI disease in a closed population eventually the disease
reaches the full population. Nevertheless, this provides a starting point from which we might be
able to develop a tractable model that does capture “birth” and “death”.
We adapt the EBCM approach to accommodate “births” and “deaths” representing entry into
and exit from the at-risk population. We show that the resulting equations accurately predict the
outcome of simulations in the large population limit, and our primary focus is on using the model
to investigate the role that concurrency can play in the spread of a “Susceptible–Infected” (SI)
disease such as HIV.
Our goals in this paper are:
1. To demonstrate an analytic model for disease spread in a dynamic population with concur-
rency and show that it exactly predicts simulated dynamics in the large population limit.
2. To use the model to identify important regimes under which concurrency does or does not
have an important effect and to understand the underlying mechanism by which this occurs
in the model.
3. To explore what features of these underlying mechanisms would need to be preserved in real-
world scenarios in order for concurrency to have (or not have) a major impact on population-
scale outcomes.
This paper is not intended to be an authoritative statement about the role of concurrent relation-
ships in Africa, rather we hope that an improved understanding of the underlying mechanisms will
improve the quality of the discussion.
Materials and Methods
In this section we introduce our stochastic population and disease model, state the governing
equations for the large population limit, and briefly outline their derivation. The full derivation is
given in the Supporting Information (SI).
Population/Disease Assumptions
We assume discrete time. This assumption is made to simplify the simulations we use to validate
the analytic model. The continuous time version of the analytic model is presented in the SI.
We initialize the network as a configuration model network [34]. In each time step actions occur
in the following specific order (illustrated in Fig. 2):
1. Each partnership connecting a susceptible to an infected individual transmits infection with
probability τ .
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Figure 2: Sequence of events in each time step. We begin with a network with some infected
individuals (red). Then infected individuals transmit to some partners (red edges). Then some
individuals leave the population (white). Other individuals are born (blue). Then some partnerships
break (dashed). Finally new partnerships are created so that the new individuals, the individuals
whose partners left, and the individuals whose partnerships broke all return to their target number
of partners. The sequence of events then repeats.
2. Individuals leave the population independently with probability µ, freeing their partners to
form a replacement partnership in step 5.
3. Next µN new individuals arrive where N is the imposed average population size. Each new
individual’s “target degree”, or desired number of partners, k is assigned from the imposed
degree distribution with probability P (k). The individual is given k free “stubs” or half-edges
which will pair with other stubs to form partnerships.
4. Each existing partnership ends independently with probability η, freeing up the two stubs
involved.
5. Free stubs are paired together at random until all individuals reach their target number of
partners. If two stubs are chosen that come from the same individual or would duplicate an
existing or a just-terminated partnership, they are left unpaired until the next time step (in
the large population limit, this has a negligible impact).
This process is then repeated for the next time step. These assumptions are similar to those
of [19, 20]. Python code implementing these steps is provided as a supplement. We will present an
analytic model that captures the large-population deterministic limit of these assumptions.
For the corresponding simulations, we choose the time step of the discrete-time framework
to balance competing interests. We need a small time step so that µ, η, and τ are small (at
leading order they are proportional to the time step), otherwise the arbitrary order of events
impacts outcomes. However, for too small of a time step (and also in the continuous-time limit)
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Parameter Description
k The “degree”, or number of partners, an individual has (fixed in time).
P (k) The probability a random individual has degree k.
µ
The probability a random individual will leave the population in a given
time step.
τ The transmission probability in a time step.
η The probability a partnership will end in a time step.
ρ The proportion of the population randomly infected at t = 0.
b
The number of individuals entering the population each time step (assumed
to be constant).
ψ(x)
∑∞
k=0 P (k)x
k: The probability generating function of the degree
distribution.
pb
1− (1−µ)(1−η): The probability that a test individual’s partnership will
end (break) because either the partnership ends naturally (rate η), or the
partner leaves the population (rate µ). It does not include the possibility
of the test individual leaving.
Pe
(1−µ)(η+µ−ηµ)
(1−µ)(η+µ−ηµ)+µ : The probability that a newly formed partnership will be
with a previously existing individual.
N b/µ: The average population size.
Table 1: The parameters for our simulations and equations. The last four are derived from
the previous parameters.
few partnerships end in a time step. This makes it difficult for nodes to immediately find new
partners. As the population size increases this becomes less of a problem so smaller time-steps
become feasible. However, the computational effort becomes greater.
Governing equations
We give an overview of the derivation of the deterministic equations governing the susceptible
and infected fractions. These equations are based on the “Edge-based Compartmental Modeling”
approach of [40, 27, 28, 15].
Tables 1 and 2 summarize the parameters and variables of the model respectively. The model
parameters are the initial fraction infected ρ, the per-time-step death probability µ, number of
births b, transmission probability τ , and partnership change probability η. In addition to time t,
the key independent variables are the age of an individual and the age of a partnership. The age of
an individual gives some information about that individual’s status (a recent entrant is generally
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Variable Description
t Time
u The test individual
au
The age of test individual u, measured so that au = 0 in the first time step
after u is born.
ae
Age of an partnership of interest, measured so that ae = 0 in the first time
step after the partnerships forms.
S(t)
The proportion of the population that is susceptible at time t, equivalently
the probability a randomly selected individual is susceptible at time t, or
equivalently the probability a test individual is susceptible at time t.
I(t) 1− S(t): The proportion infected at time t.
s(t, au) The probability a test individual of age au is susceptible at time t.
Θ(t, au)
The probability a stub belonging to u has not transmitted infection to it
from a partner by the start of time step t.
ΦS(t, au)
As for Θ (no partner has transmitted to u through the stub), but with
the additional requirement that at the start of time step t the partner is
susceptible.
ΦI(t, au)
As for Θ (no partner has transmitted to u through the stub), but with
the additional requirement that at the start of time step t the partner is
infected.
φS(t, au, ae)
The probability that a stub belonging to an age au individual has not
transmitted infection to it by time t, is connected to a susceptible partner,
and the current partnership (or “edge”) has age ae.
χ(t, ae)
The probability that an age ae partnership (or “edge”) of a test individual
connects to a susceptible individual.
Table 2: The variables for our equations.
less likely to be infected than one who has been in the population for a while). In addition the age
of a partnership gives information about the age of the partner (a partnership cannot be “older”
than the partner). In calculating the risk an individual has from its partners, we need to account
for the probability the partner has a given status. This depends on the age of the partner, which in
turn depends on the age of the partnership, which itself is dependent on the age of the individual.
To sort out the dependencies, the individual age and the partnership age are needed as independent
variables. The resulting equations are low-dimensional, but are significantly more involved than
even the dynamic network models presented in [28].
We seek the susceptible and infected fractions of the population S and I. We outline a simplified
derivation ignoring some details of the initial condition and assuming the population has equilibrium
size N = b/µ. The probability that a random individual u has age au is µ(1 − µ)au because the
proportion born in any time step is µ (it must balance the proportion that die) and the probability
of surviving au time steps is (1 − µ)au . The probability that a random individual of age au and
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with ku partners is susceptible is Θ(t, au)
ku where Θ(t, au) is the probability a random partner (or
its predecessors along the same stub) has not transmitted to u. Thus the probability a random
individual is susceptible is
S(t) = µ
∞∑
au=0
(
(1− µ)au
∑
k
P (k)Θ(t, au)
k
)
Introducing the probability generating function ψ(x) =
∑
k P (k)x
k, gives s(t, au) = ψ(Θ(t, au))
is the probability an age au individual is susceptible. This expression then simplifies to S(t) =
µ
∑
(1− µ)aus(t, au). The probability a random individual is infected is I(t) = 1− S(t).
We now derive an equation for Θ by noting that Θ(t, au) = Θ(t − 1, au − 1) − τΦI(t − 1, au −
1) where ΦI is the probability that the partner is infected and neither it nor any predecessor
has transmitted to u. We find ΦI by first solving for ΦS , the probability that the partner (and
predecessors) have not transmitted and the partner is susceptible, and using ΦI = Θ − ΦS . The
derivation for ΦS is given in the SI. It is similar to the derivation of S, but requires additional
handling of the possible ages of the partner because the age distribution of the partners is different
for partnerships of different ages.
Once we incorporate the initial condition and the full details of deriving ΦS , the governing
equations are
S(t) = µ
∞∑
au=0
(1− µ)aus(t, au)
s(t, au) =
{
ψ(Θ(t, au)) au < t
(1− ρ)ψ(Θ(t, t)) au ≥ t
I(t) = 1− S(t)
Θ(t, 0) = 1
Θ(0, au) = 1
Θ(t, au) = Θ(t− 1, au − 1)− τΦI(t− 1, au − 1) t, au ≥ 1
ΦI(t, au) = Θ(t, au)− ΦS(t, au)
ΦS(t, au) = (1− pb)auφS(t, au, au) + pb
au−1∑
ae=0
(1− pb)aeφS(t, au, ae)
φS(t, au, ae) = Θ(t− ae, au − ae)χ(t, ae)
χ(t, ae) =

(1− ρ)ψ′(Θ(t,t))〈K〉 ae ≥ t
(1− Pe)ψ
′(Θ(t,ae))
〈K〉
+Peµ
t−1∑
av=ae+1
(1− µ)av−ae−1Θ(t− ae, av − ae)ψ
′(Θ(t,av))
〈K〉 ae < t
+Pe(1− ρ)Θ(t− ae, t− ae)ψ
′(Θ(t,t))
〈K〉 (1− µ)t−ae−1
We provide a full derivation of this model and give a continuous-time differential equations version
in the Supporting Information.
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Specific modeled population
Although the equations allow different individuals to have a different number of partners, except
where specifically noted we focus on populations in which all individuals have the same number
of partners. In particular, this eliminates the need to consider how per-partnership transmission
rates may depend on the individual’s number of partners. This allows us to focus on concurrency
without the effect of some individuals having more frequent sexual activity than others.
So for our comparisons, ψ(x) = xk, 〈K〉 = k for some fixed value k. As a base case, we
consider serial monogamy where each individual has a single partner (k = 1). Transmission occurs
in a time-step with probability τ1 and partnerships end with probability η1. Individuals leave the
population with probability µ.
We compare this with homogeneous populations having concurrency. We assume that for dif-
ferent values of k the populations are arranged such that the cumulative number of partners an
individual has over a long period of time is the same. So populations with smaller k must have
faster turnover. This implies that η = η1/k so that the k partnerships each lasts k times as long.
Similarly we assume that the expected number of transmissions an infected individual would cause
in a time step is the same. This requires τ = τ1/k.
Advantages of an analytic model
There are a number of important benefits to having an analytic model (even if it can only be solved
numerically) as opposed to relying on stochastic simulation. In general, an analytic model allows us
to gain much more insight into a system because the mathematical relationships that emerge can
often be interpreted as an interaction between different physical effects from which we understand
how system behavior emerges. In contrast, with stochastic simulation it is difficult to extract those
mathematical relationships.
We highlight several practical advantages of analytic models.
• If our goal is to predict the large-population behavior, a single stochastic simulation may take
much longer and use much more memory than a numerical solution of the analytic equations:
even in the simplest well-mixed homogeneous population, we must have enough individuals
in the simulation to accurately capture the average, while the numerical solution only needs
to track the average. In our comparisons the numerical solution can run hundreds of times
faster than a large stochastic simulation, and use several orders of magnitude less memory.
• If we want to see how the equilibrium size changes as parameters change, we can simulate to
equilibrium, then change the parameters a bit and simulate further watching the system relax
to the new equilibrium. With the numerical equations, we can do something similar, but once
we identify the equilibria for multiple parameter values, we can then give good estimates of
the equilibrium variables at new parameters. This can be fed into the numerical solution as
an initial condition, allowing for dramatically faster convergence. We cannot use the same
sort of extrapolation to find good initial conditions for a new stochastic simulation.
• The analytic model allows for the application of mathematical tools that are difficult to adapt
to simulations. For example, the numerical solution of the differential equations version can
use adaptive step size and other numerical techniques. We can look for properties of equilibria
by assuming that the analytic variables do not change. We can look for relationships between
the parameters which determine when epidemic growth is possible.
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Figure 3: Comparison of analytic predictions and stochastic simulations: (Left) Stochastic
epidemic simulations in populations of average sizeN = 102, 103, 104 and 105 with k = 3, η = 0.2/3,
τ = 0.05/3, ρ = 0.02, and µ = 0.01. As N increases, the simulations converge to the analytic
prediction. (Right) Comparison of analytic predictions and simulations for different values of k,
with η1 = 0.1, τ1 = 0.1, ρ = 0.02, µ = 0.01 and average population size N = 10
4 with τ = τ1/k and
η = η1/k. We find excellent agreement between predictions (thick dashed curves) and stochastic
simulations (thin solid curves).
Results
In this section we briefly compare the analytic model with simulations to show that the analytic
model gives accurate predictions. We then use the analytic model to investigate the impact of
concurrency on the endemic equilibrium and on the early growth rates. The impact of concurrency
saturates in both cases, with the impact on the endemic equilibrium saturating at lower levels of
concurrency than the impact on early growth.
Accuracy of the analytic model
Figs. 3 and 4 compare solutions of the analytic model with stochastically simulated epidemics across
a range of conditions. The left plot of Fig. 3 shows that as the population size increases, stochastic
simulations converge to the predicted dynamics. The right plot considers populations in which all
individuals have k partners for k = 1, 2, 3, 4, and 5 with τ = τ1/k and η = η1/k for η1 = τ1 = 0.1
and µ = 0.01. Simulations and predictions are a good match for different values of k.
Figure 4 looks at disease spread in populations with heterogeneous degrees, again showing
excellent agreement between stochastic simulations and analytic predictions.
Our main conclusion from Figs. 3 and 4 is that the equations accurately predict the large-N
dynamics of simulations regardless of the parameters used.
Further observations
From the left plot in Fig. 4 we infer that for a given population, the initial proportion infected ρ
does not influence the final state. At small ρ, the early dynamics are dominated by new infections
10
0 50 100 150 200
t
0.0
0.2
0.4
0.6
0.8
1.0
Fr
a
ct
io
n
 i
n
fe
ct
e
d
0 20 40 60 80 100
t
0.0
0.2
0.4
0.6
0.8
1.0
Fr
a
ct
io
n
 i
n
fe
ct
e
d
µ= 0. 001
µ= 0. 01
µ= 0. 1
µ= 0. 2
µ= 0. 5
Figure 4: Comparison of dynamics from analytic predictions and stochastic simulations
in populations with heterogeneous degree: (Left) Disease spread in populations with average
size N = 104 and degree probabilities P (2) = P (7) = 1/2. The parameters are τ = 0.01, η = 0.005,
and µ = 0.01. The initial fraction infected ρ varies. (Right) Disease spread in populations with
average size N = 104 and degree probabilities P (1) = 1/2, P (10) = 1/3, and P (20) = 1/6.
The parameter µ varies between populations. The remaining parameters are η = 0.05 and τ =
0.1. In both plots the dashed curves are analytic predictions and thin solid curves are stochastic
simulations.
to high- and low-degree nodes. At large ρ they are dominated by removal of infected high- and low-
degree nodes. Interestingly, we see that for some intermediate values of ρ the prevalence initially
grows and then decays. At these intermediate values, initially more high-degree nodes are being
infected than are leaving while more low-degree nodes are leaving than being infected. Thus the
two sets of nodes have opposing impacts on the dynamics. In this case, the growth in high-degree
infections is initially the dominant effect, but it saturates while many low-degree infected individuals
are still being removed.
From the right plot of Fig. 4, we infer that increasing the population turnover rate decreases
the proportion infected. This is not particularly surprising as it implies that infected individuals
leave the population sooner, having had less opportunity to cause further infections.
Impact of concurrency
We now specifically explore the model predictions as we change the amount of concurrency. The
right-hand plot of Fig. 3 provides a special case of our more generic results. Interestingly we see
that the equilibrium level does not vary significantly as concurrency increases, but the early growth
rate does. Figs. 5 and 6 show how the equilibrium infection levels and early growth rates change
as k changes for a range of values of η1 and τ1.
Fig. 5 shows that the impact of concurrency on the equilibrium epidemic size can be significant,
but that the effect of increasing k may saturate quickly. The impact of concurrency is greatest if
the partnership duration is long (η1 small). For much of parameter space, Fig. 5 suggests that once
a little concurrency is present, increased concurrency has little further effect on the equilibrium
size.
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Figure 5: Comparison of equilibrium sizes for different values of k: The equilibrium fraction
infected for µ = 0.01 and different η1 and τ1. We use the same axes η1 and τ1, taking η = η1/k and
τ = τ1/k. (Top left) k = 1, (Top right) k = 2, (Bottom left) k = 3, and (Bottom right) k = 4. As k
increases, the figures converge: the effect of concurrency on the equilibrium size quickly saturates.
In Fig. 6, we demonstrate that in our model concurrency has a larger effect on the growth of
the epidemic than on the equilibrium size. Although the impact of increasing concurrency on the
early growth eventually saturates, it does so at larger k than for equilibrium size.
Figures 5 and 6 both show that saturation occurs soonest at lower transmission rates and higher
partnership turnover rates, where the probability of multiple transmissions in a partnership is small.
Discussion
We now discuss mechanisms whereby the impact of concurrency saturates, explore the implications
for intervention design, and list caveats because of important effects neglected in our model.
We designed our comparisons so that, for different k, the number of partners an individual
has over a long period of time and the total number of interactions within each partnership are
the same. Thus we know that the effects we observe are not explained by within-population het-
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Figure 6: Comparison of early growth with different levels of concurrency: Contour plots
of ∆I/I once the dynamics have entered the early exponential phase. (Top left) k = 1, (Top right)
k = 2, (Bottom left) k = 3, and (Bottom right) k = 4. Although eventually the change saturates
with larger k, it does not saturate as quickly as the equilibrium size does.
erogeneity in degree, within-population heterogeneity in sexual activity rates, between-population
differences in typical life-time number of partners, or between-population differences in the number
of transmissions an individual causes per time step. All of these effects have been removed. Each
population is homogeneous and they differ only in the number of concurrent partnerships.
To understand why concurrency does or does not matter in the different cases we take the
perspective of the disease, observing transmission events and their outcomes. If concurrency has a
significant impact on the population-scale spread of disease, it must be possible to infer the existence
of concurrency by exploring the population structure in the same way the disease spreads. So we
ask ourselves, “how easily can the disease measure the concurrency?”
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Figure 7: Scenarios for low transmission rates: (top) Serial monogamy case in which each
partnership transmits once. (middle and bottom) Concurrent partnership case in which each part-
nership transmits once, with the order of transmission events differing in the two rows. Without
the shading to denote the partnerships, it would not be possible to infer which cases exhibit con-
currency, so we expect similar population-scale outcomes.
Low transmission rates/fast partnership turnover
In our model, we observed that concurrency has a reduced effect at lower transmission rate or if
the partnership turnover rate is large. We now investigate why this is which will help us identify
whether these observations should hold in the real world.
Looking back at Fig. 1, we see that if we ignore the shading that designates when a partnership
is in existence or not, it is still possible to infer which cases correspond to concurrent relationships
by looking at the dashed lines that represent potential transmission events (that is interactions that
would cause infection if the recipient were susceptible). The most obvious sign of concurrency is
that at least one transmission event in one partnership lies between sequential transmission events
in the other partnership.
Investigating this closer in Fig. 7, we see that indeed in the low transmission rate limit, we
are unlikely to be able to distinguish between concurrent and serial partnerships by observing
potential transmission events. Once almost every transmission event is to a different partner, the
relevant detail is simply the interval between transmission events. The specific details of how long a
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partnership lasts, or how many concurrent partnerships exist are only marginally relevant. As long
as the probability of transmitting twice to the same partner is negligible, the well-mixed population
assumption would provide the same prediction (see also the “time-scale approximation” of [22] for
more discussion of this). So the impact of concurrency when τ1/η1  1 is negligible.
Equilibrium sizes
We now turn to the equilibrium sizes which are predicted to be relatively insensitive to concurrency
across much of parameter space. Before investigating this, we highlight that many real populations
are likely to have low partnership turnover rates (η1), for which our model predicts the largest role
of concurrency.
To explain the insensitivity of the equilibrium to concurrency, we note first that at equilib-
rium, an average infected individual causes one additional infection before leaving the population.
Consider now a serially monogamous population and a population with concurrency, both at equi-
librium, and consider a single individual who becomes infected.
As noted in the introduction, by itself, concurrency does not cause an infected individual to
be more or less likely to transmit to a newly acquired partner. Rather, concurrency increases the
probability an individual who is currently susceptible will later transmit to its currently susceptible
partner.
So for concurrency to affect the equilibrium level, when an individual becomes infectious he
or she must have a non-negligible probability of infecting an existing partner at equilibrium. At
equilibrium, we only expect one successful transmission (some other transmissions will fail because
the recipient is already infected). If the number of future partners is large compared to the number
of current partners, we would expect that the one transmission is much more likely to go to a future
partner than a current partner.
Put another way, if the risk to a susceptible individual from forming a new partnership with an
already infected individual is much higher than the risk that an existing susceptible partner will
become infected, then concurrency will not be a significant factor.
Transient growth
We previously observed that concurrency can play a significant role in the early spread of disease
even in scenarios where it has little effect on the long-term equilibrium. In this section we first
address why the effect of concurrency saturates. Then we look at why the saturation occurs at
higher levels of concurrency than for the equilibrium infection rates. We note that for a given
average number of transmissions, the early growth is higher if those transmissions are concentrated
earlier in the infectious period [42].
Looking at the disease’s perspective, early in an epidemic with a highly infectious disease, when
an individual with many partners becomes infected, there will be rapid successful transmissions
to many different partners. In contrast, in the serial monogamy case, there will generally be a
delay following a successful transmission because a partnership change is required before the next
successful transmission: the partnership dynamics constrain the spread. Thus in this scenario
concurrency is expected to have an important impact on the early rate of spread.
As concurrency increases, we are keeping the same number of transmissions per partnership, but
only the first transmission in a partnership is successful. By increasing concurrency, a larger fraction
of the early transmissions an individual causes are the first transmission of the given partnership.
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Increasing concurrency thus reduces the effect of local depletion of susceptibles. At high enough
concurrency the infected individual does not need to replenish its susceptible partner supply by
changing partners. At this point, further concurrency will have little impact.
To explain why the saturation of concurrency occurs at higher levels for the growth rate than
for the equilibrium level, we note that for determining the equilibrium, what matters is how many
infections an individual causes, but the timing is not significant. The early growth however depends
not just on how many infections are caused, but also on how quickly those infections occur. So the
equilibrium is most affected by the fact that concurrency can increase the number of transmission
chains, while the early growth is also affected by the fact that concurrency increases the speed with
which those transmission chains are traced. Additionally, in the early growth regime, the increased
number of transmission chains has a larger effect than near equilibrium where a non-negligible
fraction of those additional chains are blocked by existing infection.
Implications for intervention design
A major source of controversy about designing interventions to reduce concurrency is that it nec-
essarily takes resources away from other interventions, and so those who question the magnitude
of its effect understandably question the wisdom of implementing interventions.
Concurrency reduction would reduce transmissions early in the infectious period. In contrast,
many interventions under consideration require identifying infected individuals and reducing their
probability of onwards transmission. As these interventions are scaled up, a larger proportion of
transmissions will be from more recently infected individuals increasing the relative value of inter-
ventions preventing transmissions from recently infected individuals. Thus concurrency reducing
interventions may be a good complement to other interventions or a good followup once these other
interventions are widely implemented.
We additionally note that our model raises the possibility that concurrency may have played a
role in the rapid growth of the HIV epidemic in some regions, but that the role of concurrency in
determining the resulting level of infection may have saturated. Thus, now that the epidemic is well-
established, moderate reductions in concurrency might not lead to a rapid decay in the epidemic.
This raises the threshold required for concurrency reduction to be effective: for a wide range of
parameters reducing concurrency from a high level to a moderate level has much less impact on
the epidemic than reducing concurrency from a moderate level to a low level. Thus concurrency-
reducing interventions in well-established epidemics may be most effective in lower-concurrency
settings.
An important setting which is not investigated in our model is the case in which a significant
fraction of the population does not engage in concurrency. For these individuals, we would expect
concurrent relationships of their partners to be a major source of their infection risk. Thus an
intervention which encourages non-concurrent individuals to ensure that they partners who are
also non-concurrent may well be successful. Our model could be used to test this with minor
modifications.
Caveats
There are a number of caveats of our study that must be highlighted to avoid overinterpreting
these results. Understanding these limitations and why they might arise gives guidance on when
we should expect concurrency to be important.
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• Acute Phase: Before mounting an immune response, an individual’s viral load is several
orders of magnitude larger than after the immune response develops. During this early phase
infectiousness is dramatically increased [36, 3, 37, 5, 38]. If the individual has multiple
partnerships, then many more infections can happen in this phase than would be seen if the
individual were only in contact with its infector [7].
• Impact of future interventions As “treatment as prevention” or other interventions are
implemented, it is likely that later partners will be at lower risk because treatment will reduce
an individual’s infectiousness. This will increase the role of transmissions occurring early in
an infectious period, increasing the relative role of concurrency.
• Heterogeneous degree: Some people have many more partnerships than others [21]. They
generally become infected sooner, and in turn transmit to more individuals. Even if many
individuals do not engage in concurrent relationships, if there a few with many concurrent
partners, the effects may still be present. This provides an opportunity to reduce disease
transmission through an intervention that encourages those without concurrent relationships
to ensure their partners also do not have concurrent relationships.
• Temporal behavior changes: If the disease dynamics are driven by individuals having
periodic high-risk episodes between long-term relationships, then the assumptions of this
model are invalid. To correct this, the model must be adapted to allow for periods of high
risk behavior, for example when a partnership ends.
• Age structure: If there is age-structure in the contact patterns, different effects may be
seen. For example, we might think of the younger cohort as a population which has not yet
been invaded by infection. In this case, the results about early growth as the disease invades
this subpopulation may be more relevant than our model predicts. Reducing concurrency
could be expected to play an important role in slowing the invasion of this younger cohort.
• Coital dilution: We have assumed that the transmission rate scales such that individuals
have effectively the same total number of sexual acts regardless of their number of partners.
This dilutes the number of acts per partnership, and to address this we extended the part-
nerships. This allows us to isolate the effect of concurrency from the effect of frequency
of sexual acts. However, if concurrent relationships are associated with more (or less) fre-
quent sexual acts, then the conclusions we reach here may not be valid. To correct for this, we
would need to appropriately weight the transmission rates based on the number of concurrent
relationships each partner has [2].
Conclusions
We have derived an analytic model which accurately reproduces simulated SI epidemics in a pop-
ulation with concurrent relationships and demographic turnover. We use this model to isolate the
role of concurrency in the spread of a disease such as HIV.
Although the model is highly simplistic, it can be generalized to incorporate more realism, and
it can be used to help us understand important features of the role of concurrency in HIV spread.
We see first that the impact of concurrency on the equilibrium size of SI epidemics can saturate.
Consequently interventions targeting concurrency may have little impact unless they come close
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to eliminating concurrent relationships. However, we see a more significant role for concurrency in
determining the early growth rate. As concurrency increases, the early growth is increased, and the
effect saturates at higher concurrency levels than for the epidemic size. Thus reducing concurrency
is likely to have more impact on early growth than on the final equilibrium.
An important additional observation from our analysis is that we can make significant progress
by focusing on the “disease-eye” view of the population [1]. Using this, we have been able to explain
why the numerical predictions of the model follow from the assumptions, and also gain insight into
conditions under which we could expect our predictions to be robust to real-world conditions.
Our model is intended as a framework for developing more realistic models. Our goal has been
to provide this framework and clearly demonstrate that it is possible to use analytic models to
explore disease spread in populations with concurrent relationships with demographic turnover.
The predictions our model has provided are true for the simplistic assumptions made. More careful
models will be needed to identify conditions under which interventions targeting concurrency will
be effective. These models will need to incorporate additional effects such as the acute phase of
infection and more realistic information about degree distributions and correlations.
Our modeling introduces new issues which have not previously been considered in the concur-
rency discussion. In particular, even if a population has significant concurrency and even if that
concurrency played a major role in the establishment and growth of the HIV epidemic in some
population, it is not guaranteed that concurrency plays an important role in the current levels of
infection. Thus although concurrency may cause an epidemic to grow quickly to its equilibrium, it
is not clear that once the population reaches equilibrium reducing concurrency would significantly
affect the equilibrium.
Regardless of the magnitude of the current impact of concurrency, it is likely that interventions
such as TasP will disproportionately reduce transmissions caused later in the infectious period
compared to transmissions caused earlier in the infectious period. As this happens, the relative
impact of concurrency will increase.
Supporting Information
Our primary goal in the Supporting Information is to derive the governing equations. Although
in the main text we assume all individuals have the same number of concurrent partners, in our
derivation here we allow different individuals within the same population to have a different number
of concurrent partners as long as all partnerships have the same transmission probability and typical
duration. These assumptions could be modified and a number of other complexities added to the
model we develop here, but we do not attempt this now.
Stochastic population and disease model
We now describe the stochastic rules we assume govern the population and disease dynamics. We
use a discrete-time model. We begin with the population dynamics in the absence of disease. At
each time step, Nµ individuals enter the population, and each individual has probability µ to
independently leave the population. This leads to an equilibrium population size of N , but with
variation around this value.
Each individual u has a constant number of partners ku which is assigned independently to u
when u enters the population. P (k) gives the probability that ku = k. We think of u as having ku
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“stubs” (also called “binding sites” by [19, 20]). The stubs pair with stubs from other individuals
to form partnerships. When a partnership ends the two newly freed stubs join with other free stubs
to form new partnerships. We assume that individuals immediately replace their partners so that
at the start of each time step all individuals have a full set of partners ([28] has discussion of how
to include more complicated partnership dynamics.).
We are interested in the epidemic timescale, which is longer than the individual’s active period.
So we must include “birth” and “death” or equivalently immigration and emigration.
We begin with a fraction ρ of the population randomly infected. In each time step, multiple
events can happen. Since the order of events can matter (a partnership cannot transmit after it
ends), we provide a consistent order, shown in figure 2. First, infected individuals transmit to
their susceptible partners independently with probability τ . Second, individuals may “die” (or
leave the population) independently with probability µ. Third, µN new individuals are added to
the population (so the average number present is N) and assigned stubs. Fourth, each remaining
partnership breaks with probability η. Finally, the unpaired stubs form new partnerships, subject
to the constraint that old partnerships are not reformed and individuals do not join to themselves.
In simulations, these constraints are occasionally not satisfied, in which case the corresponding
individuals wait a time step before attempting to form new partnerships. In a large population,
the impact of this failure is negligible, and for our analytic equations below, we can assume that
they are satisfied.
Equation Derivation
We now derive the discrete-time equations presented in the main text as well as a continuous-time
version. These equations govern the large-population limit of our model.
Preliminaries
It will be useful to define the function
ψ(x) =
∑
k
P (k)xk
to be the probability generating function of the degree distribution. It has some important prop-
erties: ψ(1) =
∑
P (k)1k = 1, ψ′(1) =
∑
kP (k)1k−1 = 〈K〉 where 〈·〉 denotes the mean of the
random variable.
Our derivation is based on [28]. We review the concept of a “test individual” (effectively
equivalent to the cavity state of [14]). We start with the assumption that the population-scale
dynamics are deterministic in the large population limit. A direct consequence of this assumption
is the observation that the probability a randomly selected individual has a given status equals the
proportion of the population with that status.
Although in the asymptotic limit, they have the same value, calculating the probability a
random individual has a given status turns out to be simpler than calculating the proportion of
individuals in each state. This is because of a simplification that results from the observation
that the probability a single randomly chosen individual u has a given status is not affected if we
prevent u from infecting any other individuals (Although it is not necessary here, it may be helpful
to recognize that that the assumption the stochastic process exhibits deterministic population-scale
dynamics means that a change of out come for a vanishingly small fraction of events does not alter
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Figure 8: Basic transitions of individuals from time t to t+1. At each time step, death occurs with
probability µ. At population equilibrium, the proportion of the population that has age 0 is thus
the number born divided by the total population, that is, µ = b/N . The class S can be subdivided
based on how long an individual has been in the population. Note that deaths are exactly balanced
by births (at population equilibrium).
the population-scale dynamics.). If we prevent u from transmitting to its partners, then the status
of its partners become independent of one another.
Guided by this, we define a test individual to be an individual u chosen uniformly at random
from the population and prevented from transmitting infection. We have the following sequence
of questions which have identical answers if the dynamics are deterministic: Given the initial
proportion infected ρ,
1. What fraction of individuals are susceptible or infected at time t?
2. What is the probability a random individual is susceptible or infected at time t?
3. What is the probability a randomly chosen test individual is susceptible or infected at time
t?
The first two equations have the same answer because we assume ρN is large enough that the
dynamics may be treated as deterministic. The last two equations have the same answer because
preventing a single individual u from transmitting does not affect its probability of changing status
(we highlight that we are not asking what proportion of nodes are in each state once u is prevented
from transmitting).
We start our calculations with the goal of finding S(t) and I(t) using figure 8. The processes
such as death and aging and birth are relatively straightforward to model. However, the probability
an individual becomes infected in a time step is not independent of the individual’s age: For
example, an individual who has been in the population longer will have a different distribution
of partnerships from someone who has only recently joined. Consequently we must subdivide
S(t) based on individual age au. These subdivisions are shown in figure 9. At equilibrium, the
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Figure 9: The subdivisions of class S. The variable s(t, au) denotes the probability that an age
au individual is susceptible. Thus s(t, 0) = 1. The number of individuals in each age class is
µ(1 − µ)au , representing the fact that a proportion µ are born in a given time step, and of these
(1 − µ)au survive to step au. The arrows show the fluxes out of the compartment corresponding
to susceptible individuals of age au. There is no need to subdivide the I(t) compartment. Rather
than calculating the flux along each arrow, we will derive explicit expressions for s(t, au).
proportion of the population which is age 0 is µ (which equals b/N), and the probability that such
an individual is susceptible is s(t, 0) = 1. At each subsequent time step, these aging individuals
are removed with probability µ, and so the proportion of the population with age au is µ(1−µ)au .
The probability that such an individual is susceptible is defined to be s(t, au). To find s(t, au), we
turn to Θ(t, au), the probability that a stub belonging to an age au test individual u has never been
involved in a transmission to u. Once we know that, then the probability a test individual of age
au and ku partners is susceptible at time t is Θ(t, au)
ku . Averaging this over the entire population
of age au individuals the probability an age au individual is susceptible is
s(t, au) =
{
ψ(Θ(t, au)) au < t
(1− ρ)ψ(Θ(t, au)) au ≥ t
where we recall
∑
k P (k)x
k = ψ(x), and the 1 − ρ factor in the second term accounts for the fact
that the individual would be infected at t = 0 with probability ρ.
The fraction susceptible is thus
S(t) = µ
∞∑
au=0
(1− µ)aus(t, au)
The probability of being infected is
I(t) = 1− S(t)
We must now derive an expression for s(t, au).
The focus of our calculations is on determining Θ(t, au). As a boundary condition we have
Θ(t, 0) = 1
stating that when an individual is first introduced, it has not yet received any infection. Similarly
we have the initial condition
Θ(0, au) = 1
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Figure 10: Basic transitions of partnerships from time t to t+ 1 (from the perspective of an age au
test individual who does not die at time t). At each time step the partnership ends with probability
µ+ η. . The class ΦS can be subdivided based on how long a partnership has existed.
pbφS(t, au, 0)
ΦS(t, au)
· · · pb(1− pb)auφS(t, au, ae) · · ·
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Figure 11: The subdivisions of the ΦS compartment. Arrows show the fluxes out of the subcom-
partment corresponding to partnerships of age ae. Rather than calculating the fluxes along each
arrow, we will explicitly calculate φS(t, au, ae).
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as well, stating that prior to the disease introduction, no transmissions have occurred. Looking at
figure 10, we see that the change in Θ is from transmissions which occur with probability τΦI . So
the change in Θ in a time step is −τΦI where ΦI is the probability that the stub has not previously
brought infection to u and connects to an infected partner at the start of the time step. So we have
Θ(t, au) = Θ(t− 1, au − 1)− τΦI(t− 1, au − 1)
However to do this calculation we require ΦI(t, au) which is still unknown. We can shift our
unknown from ΦI to ΦS (the probability the stub has not transmitted to u and currently connects
to a susceptible partner) by using
ΦI = Θ− ΦS .
As in calculating S, to calculate ΦS , we turn it into a sum, following figure 11. The probability
that a partnership created when u joined still exists is (1−pb)au . The probability that a partnership
has some smaller age ae is pb(1− pb)ae . So
ΦS = (1− pb)auφS(t, au, au) + pb
au−1∑
ae=0
(1− pb)aeφS(t, au, ae)
where φS(t, au, ae) is the probability that a stub belonging to an age au individual that is part of
an age ae partnership has not transmitted by time t and pb is the probability that a stub is freed
to find a new partnership (either by death of the partner, or termination of the partnership). The
one term outside the sum represents the fact that when the individual first enters the population
the stub definitely forms a partnership.
We now find φS(t, au, ae). If the partnership formed when u was born (ae = au) then this is
simply the probability the partner v is susceptible given that v has an age au partnership with u,
which we denote χ(t, au). However, if the partnership formed after u was born (ae < au), then
φS(t, au, ae) is the probability Θ(t− ae, au− ae) that the stub was not responsible for transmitting
infection to individual u prior to the current partnership forming times χ(t, ae). As Θ(t−au, 0) = 1
these coincide when au = ae, so we can write
φS(t, au, ae) = Θ(t− ae, au − ae)χ(t, ae)
We now find χ(t, ae) similarly to s(t, au). It is
χ(t, ae) =
∞∑
Av=ae
P (av = Av|ae)P (v susceptible|av = Av) .
If ae ≥ t, then we know that v was born either when the disease was introduced or earlier. Thus no
previous partnership could have transmitted to v. if we assume av = Av ≥ ae, then the probability
v is susceptible is the probability that it escaped infection when the disease was introduced 1 − ρ
times the probability that it has not been infected by any other partners. Because of how v is
selected (it is u’s partner), v is likely to have a higher degree than a randomly selected individual.
The probability v has degree kv = k is kP (k)/ 〈K〉. So the probability v is susceptible given Av is
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(1− ρ)∑k[kP (k)/ 〈K〉]Θ(t, Av)k−1 = (1− ρ)ψ′(Θ(t, Av))/ 〈K〉. Thus for ae ≥ t we have
χ(t, ae) =
∞∑
Av=ae
P (av = Av|ae)P (v susceptible|av = Av)
=
∞∑
av=ae
µ(1− µ)av−ae(1− ρ)ψ
′(Θ(t, av))
〈K〉 ae ≥ t
For ae < t there are three important cases to consider based on whether the partner was born
before or at the same time that the partnership was formed and whether the partner was born
before or after the disease was introduced.
• If the partnership formed when v was born then Av = ae for which P (av = ae|ae) = (1 −
Pe) and P (v susceptible|av = ae) =
∑
k[kP (k)/ 〈K〉]Θ(t, ae)k−1 = ψ′(Θ(t, ae))/ 〈K〉, which
measures the probability that another partner of v has not transmitted to v.
• If v was born before the partnership formed but after the disease was introduced then ae <
Av < t and P (av = Av|ae) = Peµ(1 − µ)Av−ae−1. Although u has not transmitted to v,
it is possible that a previous partner of v that was eventually replaced by u did. Thus the
probability v is susceptible is Θ(t− ae, Av − ae)ψ′(Θ(t, Av)).
• If v was born before the disease was introduced, then Av ≥ t. We again have P (av = Av|ae) =
Peµ(1 − µ)Av−ae−1, but there is an extra factor of 1 − ρ in the probability v is susceptible.
P (v susceptible|Av) = (1− ρ)Θ(t− ae, Av − ae)ψ′(Θ(t, Av)).
So for ae < t we have
χ(t, ae) =
∞∑
Av=ae
P (av = Av|ae)P (v susceptible|av)
= P (av = ae|ae)P (v susceptible|av = ae)
+
t−1∑
v=ae+1
P (av = Av|ae)P (v susceptible|av = Av)
+
∞∑
Av=t
P (av = Av|ae)P (v susceptible|av = Av)
= (1− Pe)ψ
′(Θ(t, ae))
〈K〉
+ Peµ
t−1∑
av=ae+1
(1− µ)av−ae−1Θ(t− ae, av − ae)ψ
′(Θ(t, av))
〈K〉
+ Peµ(1− ρ)
∞∑
av=t
(1− µ)av−ae−1Θ(t− ae, av − ae)ψ
′(Θ(t, av))
〈K〉
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Simplification for au > t
We claim that the value of Θ(t, au) is the same for all au ≥ t. This follows from the fact that at
t = 0 all the values are 1. By inspecting the equations for the evolution of Θ, we see that if we
assume Θ(t, au) is the same for all au ≥ t, then the change in Θ is also the same. Thus we can
assume Θ(t, au) = Θ(t, t) if au > t. This argument would break down if partnership formation were
affected by age differences.
Among the resulting simplifications is the observation that for ae ≥ t, the expression for χ(t, ae)
simplifies to (1− ρ)ψ′(Θ(t, t))/ 〈K〉.
Governing Equations
Our full system of equations becomes
S(t) = µ
∞∑
au=0
(1− µ)aus(t, au)
s(t, au) =
{
ψ(Θ(t, au)) au < t
(1− ρ)ψ(Θ(t, t)) au ≥ t
I(t) = 1− S(t)
Θ(t, 0) = 1
Θ(0, au) = 1
Θ(t, au) = Θ(t− 1, au − 1)− τΦI(t− 1, au − 1) t, au ≥ 1
ΦI(t, au) = Θ(t, au)− ΦS(t, au)
ΦS(t, au) = (1− pb)auφS(t, au, au) + pb
au−1∑
ae=0
(1− pb)aeφS(t, au, ae)
φS(t, au, ae) = Θ(t− ae, au − ae)χ(t, ae)
χ(t, ae) =

(1− ρ)ψ′(Θ(t,t))〈K〉 ae ≥ t
(1− Pe)ψ
′(Θ(t,ae))
〈K〉
+Peµ
∑t−1
av=ae+1
(1− µ)av−ae−1Θ(t− ae, Av − ae)ψ
′(Θ(t,av))
〈K〉 ae < t
+Pe(1− ρ)Θ(t− ae, t− ae)ψ
′(Θ(t,t))
〈K〉 (1− µ)t−ae−1
We can derive a differential equations version of this by treating the time step as ∆t rather than 1
and assuming that the event probabilities are all proportional to ∆t. Then taking ∆t → 0 yields
differential equations. We will use µˆ = lim∆t→0 µ/∆t and similarly define other variables.
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In the continuous time case, we find
S(t) = µ
∫ ∞
0
e−auµs(t, au) dau
s(t, au) =
{
ψ(Θ(t, au)) au < t
(1− ρ)ψ(Θ(t, t)) au ≥ t
I(t) = 1− S(t)
Θ(t, 0) = 1
Θ(0, au) = 1(
∂
∂t
+
∂
∂a
)
Θ(t, au) = −τΦI(t, au)
ΦI(t, au) = Θ(t, au)− ΦS(t, au)
ΦS(t, au) = e
−pbauφS(t, au, au) + pb
∫ au
0
e−pbavφS(t, au, ae) dae
φS(t, au, ae) = Θ(t− ae, au − ae)χ(t, ae)
χ(t, ae) =

(1− ρ)ψ′(Θ(t,t))〈K〉 ae ≥ t
(1− Pe)ψ
′(Θ(t,ae))
〈K〉
+Peµ
∫ t
ae
e−µ(Av−ae)Θ(t− ae, Av − ae)ψ
′(Θ(t,Av))
〈K〉 dAv ae < t
+Pe(1− ρ)Θ(t− ae, t− ae)ψ
′(Θ(t,t))
〈K〉 e
−µ(t−ae)
The simplest numerical method to solve this system of equations would discretize by age and apply
an Euler method, which corresponds to solving the discrete-time equations above.
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